Automated Insulin Delivery

The AJMC® Automated Insulin Delivery compendium is a comprehensive resource for clinical news and expert insights for this technology, which has revolutionized diabetes care.

Sustained Glucose Control Does Not Slow Decline of C-Peptide in Randomized T1D Study

September 16th 2022, 6:00pm


This randomized, multicenter study of children and adolescents with new-onset type 1 diabetes (T1D) investigated the effect on glucose control of a closed-loop system, using C-peptide levels to gauge response

CGM May Improve Glycemic Control in Patients With Diabetes and Cystic Fibrosis

September 12th 2022, 5:45pm


The review included data from 17 studies of over 400 patients using continuous glucose monitors (CGM).

Advanced Hybrid Closed-Loop System Helps Achieve T1D Glucose Targets in New Trial

September 7th 2022, 10:30pm


The trial followed patients with type 1 diabetes (T1D) for 6 months, evaluating outcomes in patients struggling to achieve glucose targets with the conventional treatment.

DIY Automated Insulin Delivery Systems Bring Unique Challenges to HCPs

August 27th 2022, 6:51pm


Do-it-yourself (DIY) automated insulin delivery systems have gained rapid uptake, yielding self-reported improvements in glycemic control and quality of life for patients, but creating unique challenges for health care providers (HCPs).

Parents of Youth With T1D Generally Prefer Virtual Visit for CGM Initiation

August 15th 2022, 5:10pm


The interview-based study collected feedback from 16 parents of 15 youth recently diagnosed with type 1 diabetes, finding that the majority preferred a virtual continuous glucose monitoring (CGM) information initiation visit rather than an in-person visit.

Dr Viral Shah Addresses Gap in T1D Technology Uptake

August 12th 2022, 7:38pm


More efforts need to be made to remove unconscious bias when implementing approved diabetes technologies into clinical practice for all patients, said Viral Shah, MD, an endocrinologist and scientist.

Closed-Loop Insulin Delivery Has Glycemic Benefits During Sleep at Cost of Sleep Quality

August 11th 2022, 6:20pm


Compared with sensor-augmented pump therapy, closed-loop insulin delivery increased glucose time in range and reduced hypoglycemia episodes but detracted from sleep quality.

Use of Continuous Glucose Monitoring Devices Varies by Age for Patients With T1D

July 27th 2022, 3:00pm


Probability of continuous glucose monitoring device use was highest for patients with type 1 diabetes (T1D) in middle adulthood, decreasing as older age increased.

CGM for Diabetes on the Rise in Italy, but Usage Is Still Lower Than Expected, Study Says

July 22nd 2022, 12:50pm


Children with type 1 diabetes had the highest rates of using continuous glucose monitoring and continuous subcutaneous insulin infusion in Italy, according to recent research, but economic barriers prevent widespread adoption.

Omnipod 5 May Improve Psychosocial Outcomes for Patients With T1D, Study Suggests

July 21st 2022, 5:55pm


Patients with type 1 diabetes (T1D) who used the Omnipod 5 Automated Insulin Delivery (AID) System saw significant improvements in psychosocial outcomes, including diabetes distress and hypoglycemic confidence over a 3-month period.